Insmed to present at march 2025 investor conferences

Bridgewater, n.j. , feb. 11, 2025 /prnewswire/ -- insmed incorporated (nasdaq: insm), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the following investor conferences: 45th annual td cowen healthcare conference in boston, on monday, march 3, 2025, at 9:10 a.m.
INSM Ratings Summary
INSM Quant Ranking